MARK1

Chr 1

microtubule affinity regulating kinase 1

Also known as: MARK, Par-1c, Par1c

Enables anion binding activity; magnesium ion binding activity; and tau-protein kinase activity. Involved in intracellular signal transduction; negative regulation of epithelial to mesenchymal transition; and protein phosphorylation. Located in cytoplasm; dendrite; and plasma membrane. [provided by Alliance of Genome Resources, Jun 2026]

ResearchGenerating clinical summary…

Clinical highlights

Interpreting a novel variant
This gene is strongly intolerant of loss-of-function variation in the population, so LoF variants warrant close attention. No curated mechanism annotation is available — see the mechanism card for the computational prediction and its caveats.Based on population constraint only.
0
Active trials
9
Pubs (1 yr)
P/LP submissions
P/LP missense
0.36
LOEUF
Mechanism
Some data sources returned errors (1)

omim: Error: OMIM fetch failed: 429

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Moderate LoF intolerance
LoF Constraint?
0.36LOEUF
pLI 0.600
Z-score 4.98
OE 0.21 (0.130.36)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint?
2.73Z-score
OE missense 0.64 (0.580.70)
289 obs / 452.3 exp
Mild constraint

Moderately missense-constrained (top ~2.5%)

Observed / Expected Ratios?
LoF OE?0.21 (0.130.36)
00.351.4
Missense OE?0.64 (0.580.70)
00.61.4
Synonymous OE?0.81
01.21.6
LoF obs/exp: 10 / 46.7Missense obs/exp: 289 / 452.3Syn Z: 1.87

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

MARK1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →